Diminished CD134 expression might imply difficulties in mounting effective memory immune responses in HIV(+) patients post-AHCT, and contribute to the immune features that play a role in increased susceptibility of individuals with chronic, controlled HIV infection to malignancies related to oncogenic viral infections. The gene discussed is TNFRSF4; the disease is HIV infectious disease.